Company Information

HEALTHCARE GLOBAL ENTERPRISES LTD.

NSE : HCGBSE : 539787ISIN CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse : HCG
BSE596.9518.5 (+3.2 %)
PREV CLOSE ( ) 578.45
OPEN PRICE ( ) 627.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4350
TODAY'S LOW / HIGH ( )574.60 627.95
52 WK LOW / HIGH ( )478.85 804.3
NSE596.9518.35 (+3.17 %)
PREV CLOSE( ) 578.60
OPEN PRICE ( ) 585.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 596.95 (10)
VOLUME 166224
TODAY'S LOW / HIGH( ) 574.20 600.60
52 WK LOW / HIGH ( )476.3 804.65
ChairmanB S Ajai Kumar
Company SecretarySunu Manuel
Executive DirectorManish Mattoo
Non Executive Independent DirectorGeeta Mathur
Raj Raghavan
Pradip Kanakia
Rajiv Mailwal
Bijou Kurien
Non Independent & Non Executive DirectorAnjali Ajaikumar
Akshay Tanna
Simrun Mehta
Incorporation Year : 1998

Registered Office :

Address : H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama Nagar Bengaluru,
Karnataka-560027 .

Phone : 080 - 33669999

Email :  info@hcgoncology.com 

Industry : Hospital & Healthcare Services

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.